Landmark Financial Advisors, LLC Pfizer Inc Transaction History

Landmark Financial Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $5,006 - $5,851	156 Added 2.29%	6,976 $231,000
Q2 2023 Jul 18, 2023	SELL	$36.12 - $41.79 $27,270 - $31,551	-755 Reduced 9.97%	6,820 $250,000
Q1 2023 Apr 13, 2023	BUY	$39.39 - $51.28 $2,599 - $3,384	66 Added 0.88%	7,575 $309,000
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $19,205 - $25,070	460 Added 6.53%	7,509 $0
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $42,228 - $51,550	965 Added 15.86%	7,049 $308,000
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $7,630 - $9,047	-164 Reduced 2.62%	6,084 $319,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $20,038 - $24,830	438 Added 7.54%	6,248 $306,000
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $240,069 - $355,862	5,810 New	5,810 $343,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $211,204 - $271,310	-5,381 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $193,231 - $218,899	5,381 New	5,381 $211,000
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $193,672 - $218,423	-5,783 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $193,557 - $246,124	5,783 New	5,783 $218,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Landmark Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Landmark Financial Advisors, LLC with notifications on news.